Two Sigma Advisers’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-2,467
| Closed | -$156K | – | 2695 |
|
|
2021
Q2 | $156K | Sell |
2,467
-10,241
| -81% | -$648K | ﹤0.01% | 2297 |
|
|
2021
Q1 | $1.57M | Buy |
12,708
+6,191
| +95% | +$763K | ﹤0.01% | 1395 |
|
|
2020
Q4 | $741K | Buy |
6,517
+3,636
| +126% | +$413K | ﹤0.01% | 1707 |
|
|
2020
Q3 | $344K | Buy |
2,881
+809
| +39% | +$96.6K | ﹤0.01% | 1962 |
|
|
2020
Q2 | $258K | Buy |
2,072
+1,789
| +632% | +$223K | ﹤0.01% | 2178 |
|
|
2020
Q1 | $55K | Sell |
283
-131
| -32% | -$25.5K | ﹤0.01% | 2370 |
|
|
2019
Q4 | $138K | Sell |
414
-18
| -4% | -$6K | ﹤0.01% | 2233 |
|
|
2019
Q3 | $139K | Buy |
432
+7
| +2% | +$2.25K | ﹤0.01% | 2085 |
|
|
2019
Q2 | $183K | Buy |
425
+33
| +8% | +$14.2K | ﹤0.01% | 2147 |
|
|
2019
Q1 | $221K | Buy |
392
+150
| +62% | +$84.6K | ﹤0.01% | 2091 |
|
|
2018
Q4 | $72K | Buy |
242
+20
| +9% | +$5.95K | ﹤0.01% | 2251 |
|
|
2018
Q3 | $158K | Buy |
+222
| New | +$158K | ﹤0.01% | 2116 |
|